ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to today's ANI Pharmaceuticals Third Quarter 2025 Earnings Results Call. Please note, this call is being recorded.
Ani Pharmaceuticals Inc (ANIP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Polaris Capital Management Bernard Horn | 9,700 | $765,718 | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.69 | 7,224 | $199,997.16 | 169,650 | 2022-03-21 | Filing | |
| $27.76 | 5,000 | $138,794.00 | 53,388 | 2022-03-21 | Filing | |
| $27.87 | 5,000 | $139,342.50 | 393,226 | 2022-03-21 | Filing | |
| $27.15 | 5,000 | $135,744.00 | 388,226 | 2022-03-18 | Filing | |
| $27.65 | 5,000 | $138,251.50 | 5,000 | 2022-03-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $84.33 | 500 | $42,165.00 | 74,374 | 2026-01-13 | Filing | |
| $82.40 | 1,622 | $133,652.80 | 58,564 | 2025-12-18 | Filing | |
| $82.32 | 400 | $32,928.00 | 74,874 | 2025-12-12 | Filing | |
| $81.15 | 1,800 | $146,070.00 | 25,157 | 2025-12-05 | Filing | |
| $86.88 | 8,643 | $750,903.84 | 61,405 | 2025-11-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,305,068 | $103,022,068 | 0% | |
| 2. | 240,792 | $19,008,121 | 0.03% | |
| 3. | 11,473,000 | $14,455,980 | 1.65% | |
| 4. | 151,275 | $11,941,649 | 0.04% | |
| 5. | 150,779 | $11,902,493 | 0% |
News See All
ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch
ANI Pharmaceuticals, Inc.
11 Best Pharma Stocks to Invest in for the Long Term
According to a recent White House announcement, President Trump wrote letters to 17 major pharmaceutical companies outlining the actions they could take to bring the prices of prescription pharmaceuticals...
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. 2Q 2025 Earnings Results Call. Please note, this call is being recorded.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2025 Earnings Call Transcript
Operator: Please stand by. Your program is about to begin. [Operator Instructions] Good day everyone and welcome to today's ANI Pharmaceuticals, Inc. First Quarter 2025 Earnings Results Call.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q4 2024 Earnings Call Transcript
Operator: Good morning, everyone. Welcome to today's ANI Pharmaceuticals Fourth Quarter 2024 Earnings Results Call. Please note, this call is being recorded.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's ANI Pharmaceuticals Inc Third Quarter 2024 Earnings Results Call. Please note that this call is being recorded.
10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers
The pharmaceutical industry is one of the most interesting sectors to invest in.
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q2 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. Second Quarter 2024 Earnings Results Call. [Operator Instructions].
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript
ANI Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.937 EPS, expectations were $0.98.
Hedge Fund Resource Center Billionaire Hedge Funds
